Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 15;10(5):761-772.
doi: 10.3390/tomography10050058.

Sentinel Lymph Node Mapping in Lung Cancer: A Pilot Study for the Detection of Micrometastases in Stage I Non-Small Cell Lung Cancer

Gaetano Romano  1 , Carmelina Cristina Zirafa  1 , Fabrizia Calabrò  1 , Greta Alì  2 , Gianpiero Manca  3 , Annalisa De Liperi  4 , Agnese Proietti  2 , Beatrice Manfredini  1 , Iosè Di Stefano  2 , Andrea Marciano  3 , Federico Davini  1 , Duccio Volterrani  3 , Franca Melfi  1
Affiliations

Sentinel Lymph Node Mapping in Lung Cancer: A Pilot Study for the Detection of Micrometastases in Stage I Non-Small Cell Lung Cancer

Gaetano Romano et al. Tomography. .

Abstract

Lymphadenectomy represents a fundamental step in the staging and treatment of non-small cell lung cancer (NSCLC). To date, the extension of lymphadenectomy in early-stage NSCLC is a debated topic due to its possible complications. The detection of sentinel lymph nodes (SLNs) is a strategy that can improve the selection of patients in which a more extended lymphadenectomy is necessary. This pilot study aimed to refine lymph nodal staging in early-stage NSCLC patients who underwent robotic lung resection through the application of innovative intraoperative sentinel lymph node (SLN) identification and the pathological evaluation using one-step nucleic acid amplification (OSNA). Clinical N0 NSCLC patients planning to undergo robotic lung resection were selected. The day before surgery, all patients underwent radionuclide computed tomography (CT)-guided marking of the primary lung lesion and subsequently Single Photon Emission Computed Tomography (SPECT) to identify tracer migration and, consequently, the area with higher radioactivity. On the day of surgery, the lymph nodal radioactivity was detected intraoperatively using a gamma camera. SLN was defined as the lymph node with the highest numerical value of radioactivity. The OSNA amplification, detecting the mRNA of CK19, was used for the detection of nodal metastases in the lymph nodes, including SLN. From March to July 2021, a total of 8 patients (3 female; 5 male), with a mean age of 66 years (range 48-77), were enrolled in the study. No complications relating to the CT-guided marking or preoperative SPECT were found. An average of 5.3 lymph nodal stations were examined (range 2-8). N2 positivity was found in 3 out of 8 patients (37.5%). Consequently, pathological examination of lymph nodes with OSNA resulted in three upstages from the clinical IB stage to pathological IIIA stage. Moreover, in 1 patient (18%) with nodal upstaging, a positive node was intraoperatively identified as SLN. Comparing this protocol to the usual practice, no difference was found in terms of the operating time, conversion rate, and complication rate. Our preliminary experience suggests that sentinel lymph node detection, in association with the accurate pathological staging of cN0 patients achieved using OSNA, is safe and effective in the identification of metastasis, which is usually undetected by standard diagnostic methods.

Keywords: NSCLC; OSNA; robotic surgery; sentinel lymph node.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
CT-guided injection of the [99mTc]-tilmanocept.
Figure 2
Figure 2
CT-guided injection of the [99mTc]-tilmanocept.
Figure 3
Figure 3
CT follow up after radiopharmaceutical injection.
Figure 4
Figure 4
CT follow up after radiopharmaceutical injection.
Figure 5
Figure 5
CT scan identification of a hilar lymph node as a sentinel lymph node.
Figure 6
Figure 6
SPECT scan identification of a hilar lymph node as a sentinel lymph node.
See this image and copyright information in PMC

References

    1. De Koning H.J., Van Der Aalst C.M., De Jong P.A., Scholten E.T., Nackaerts K., Heuvelmans M.A., Lammers J.-W.J., Weenink C., Yousaf-Khan U., Horeweg N., et al. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. N. Engl. J. Med. 2020;382:503–513. doi: 10.1056/nejmoa1911793. - DOI - PubMed
    1. Wu F.Z., Huang Y.L., Wu Y.J., Tang E.K., Wu M.T., Chen C.S., Lin Y.P. Prognostic effect of implementation of the mass low-dose computed tomography lung cancer screening program: A hospital-based cohort study. Eur. J. Cancer Prev. 2020;29:445–451. doi: 10.1097/CEJ.0000000000000569. - DOI - PubMed
    1. Wu F.Z., Huang Y.L., Wu C.C., Tang E.K., Chen C.S., Mar G.Y., Yen Y., Wu M.T. Assessment of Selection Criteria for Low-Dose Lung Screening CT Among Asian Ethnic Groups in Taiwan: From Mass Screening to Specific Risk-Based Screening for Non-Smoker Lung Cancer. Clin. Lung Cancer. 2016;17:e45–e56. doi: 10.1016/j.cllc.2016.03.004. - DOI - PubMed
    1. Aberle D.R., Adams A.M., Berg C.D., Black W.C., Clapp J.D., Fagerstrom R.M., Gareen I.F., Gatsonis C., Marcus P.M., et al. National Lung Screening Trial Research Team Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 2011;365:395–409. - PMC - PubMed
    1. Goldstraw P., Crowley J., Chansky K., Giroux D.J., Groome P.A., Rami-Porta R., Postmus P.E., Rusch V., Sobin L., International Association for the Study of Lung Cancer International Staging Committee and Participating Institutions The IASLC Lung Cancer Staging Project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J. Thorac. Oncol. 2007;2:706–714. doi: 10.1097/jto.0b013e31812f3c1a. - DOI - PubMed

MeSH terms